273 related articles for article (PubMed ID: 9812464)
1. [A serological study on the immunization schedule at first dose of domestic BRD II strain rubella vaccine].
Xu AQ; Song LZ; Hao SZ
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Jun; 18(3):156-9. PubMed ID: 9812464
[TBL] [Abstract][Full Text] [Related]
2. [An observation of the immuno-persistence after inoculating with the domestic BRD II strain rubella vaccine among infants and young children].
Xu A; Song L; Wang C; Wang A; Xu Q; Xiao Z; Wang S; Li M; Hao S; Li Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):117-20. PubMed ID: 11860770
[TBL] [Abstract][Full Text] [Related]
3. [Immune response of rubella vaccine in the populations with different age groups].
Xiong XW; Diao LD; Yan XL
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
[TBL] [Abstract][Full Text] [Related]
4. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
Liu BY; Feng ZX; Xu AQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
[TBL] [Abstract][Full Text] [Related]
5. A rubella outbreak investigation and BRD-II strain rubella vaccine effectiveness study, Harbin city, Heilongjiang province, China, 2010-2011.
Xu H; Gao X; Bo F; Ma J; Li Y; Fan C; Jiang L; Ma Y; Luo H; An Z
Vaccine; 2013 Dec; 32(1):85-9. PubMed ID: 24188756
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
8. [Analysis on the changing of age patterns among rubella patients after rubella vaccine immunization for children in Shandong Province, China].
Xu Q; Xu AQ; Song LZ; Zhang L; Xiao ZK; Wang CY; Li MS; Wang AL; Li Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Nov; 26(11):861-3. PubMed ID: 16676605
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
[TBL] [Abstract][Full Text] [Related]
10. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
Wang SS; Han YR; Su WN; Chen J; Zhao K
Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
[TBL] [Abstract][Full Text] [Related]
11. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
Lin DB; Kao CL; Lee CY
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
[TBL] [Abstract][Full Text] [Related]
12. Rubella susceptibility in sixth graders: effectiveness of current immunization practice.
Lawless MR; Abramson JS; Harlan JE; Kelsey DS
Pediatrics; 1980 Jun; 65(6):1086-9. PubMed ID: 7375231
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
14. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
15. The immunoglobulin response to reimmunization with rubella vaccine.
Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA
J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092
[TBL] [Abstract][Full Text] [Related]
16. Further evaluation of the optimum age for rubella vaccine administration.
Wilkins J; Wehrle PF
Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
[TBL] [Abstract][Full Text] [Related]
17. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
Nakazono N
Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
[TBL] [Abstract][Full Text] [Related]
19. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
20. The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
Samoilovich EO; Kapustik LA; Feldman EV; Yermolovich MA; Svirchevskaya AJ; Zakharenko DF; Fletcher MA; Titov LP
Cent Eur J Public Health; 2000 Aug; 8(3):160-3. PubMed ID: 10965439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
